Intervention not reported
Well‐being measures · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Well being/QOL (PARS III, PedsQL) · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
1 finding from 1 review
Intervention not reported
Disease knowledge (MyHeart) · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
1 finding from 1 review
Intervention not reported
Quality of care · Private for‐profit providers of healthcare services
1 finding from 1 review
Intervention not reported
Quality of care · Private for‐profit providers of healthcare services
1 finding from 1 review
Intervention not reported
Quality of care · Private for‐profit providers of healthcare services
1 finding from 1 review
ACT use (percentage of children under 5 years receiving ACT on the same day or following day of fever onset) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
ACT availability (percentage of outlets stocking ACTs for children under 5 years) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 2 participants
High
ACT availability (percentage of outlets stocking at least one ACT for patients of any age) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
ACT price (change in ACT prices for children under 5 years)c · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 1 participants
High
ACT market share (volume of ACTs purchased as a proportion of all antimalarials purchased; all age groups) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 2 participants
High
Use of older antimalarials (amodiaquine, sulphadoxine‐pyrimethamine; children under 5 years) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
no estimate extracted
1 study · 1 participants
High
Adverse effects (such as the number of people receiving ACTs who do not have malaria) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
ACT access (percentage of illness episodes treated with ACTs; all age groups) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
ACT targeting (percentage of ACT takers who are malaria positive; all age groups) · Patients seeking treatment for suspected uncomplicated malaria
1 finding from 1 review
All‐cause mortality · children under 5 years of age
Integrated management of childhood illness strategy showed no clear difference in mortality compared with routine care (low certainty).
1 finding from 1 review
Nutritional status · children under 5 years of age
Integrated management of childhood illness strategy showed no clear difference in nutritional status compared with routine care (low certainty).
1 finding from 1 review
Quality of care · children under 5 years of age
1 finding from 1 review
Coverage of IMCI deliverables · children under 5 years of age
Integrated management of childhood illness strategy showed no clear difference in coverage of IMCI deliverables compared with routine care (moderate certainty).
1 finding from 1 review
Satisfaction of beneficiaries · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found